IP Library › Granted Patent US 12,575,763
Granted Patent B2
US 12,575,763 · App. 17/704,824 · Granted Mar 17, 2026

Systems, devices, and methods with duration-based adjustment of sensor data

Inventors: Erwin S. Budiman (Fremont, CA); Claire Bhogal (Witney, GB); Steven Scott (Pleasanton, CA); Marc B. Taub (Mountain View, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61B5/14532A61B5/0022A61B5/076A61B5/145A61B5/14503A61B5/1495A61B5/6833A61B5/6849G16H40/40A61B2560/0223
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,575,763
App. No.
17/704,824
Granted
Mar 17, 2026
Kind
B2
Abstract

Embodiments that compensate for changes to sensor response characteristics (e.g., sensitivity) due to time durations are disclosed. The time durations can be the amount of time the sensor is in a post-manufacture packaged state prior to use, or the amount of time the sensor is in use. Sensor response changes due to other variables can also be compensated for.

Claims (71)

1 . A glucose monitoring sensor control device comprising:

a glucose sensor configured to detect glucose levels in a bodily fluid of a user, wherein the glucose sensor is configured to be positioned in the user such that when operably positioned, a first portion of the glucose sensor is configured to reside above a skin surface of the user, and a second portion of the glucose sensor is configured to reside below the skin surface and in contact with the bodily fluid of the user;

processing circuitry electrically and communicatively coupled with the glucose sensor prior to the glucose sensor being positioned in the user; and

a memory electrically and communicatively coupled with the processing circuitry, the memory comprising instructions that, when executed by the processing circuitry, cause the processing circuitry to:

collect data indicative of environmental exposure of the glucose sensor during a duration of time before use of the sensor control device by the user;

determine a wear duration of the glucose sensor, wherein the wear duration corresponds to a duration of time after use of the sensor control device by the user;

collect, from the glucose sensor, sensor data including data indicative of a glucose level in the bodily fluid;

algorithmically adjust a calibration parameter of the glucose sensor with: a first function including a first adjustment parameter and a value representative of the wear duration, and one or more additional functions including a second adjustment parameter and a value representative of the environmental exposure of the glucose sensor during the duration of time before use of the sensor control device by the user;

algorithmically process the sensor data using the adjusted calibration parameter and to determine the glucose level in the bodily fluid; and

transmit the determined glucose level to a reader device communicatively coupled with the sensor control device and configured to display the determined glucose level.

2 . The glucose monitoring sensor control device of claim 1 , wherein the first function including the first adjustment parameter and the value representative of the wear duration comprises a first adjustment function for values of the value representative of the wear duration below a threshold value and a second adjustment function for values of the value representative of the wear duration above the threshold value.

3 . The glucose monitoring sensor control device of claim 1 , wherein the first adjustment parameter and second adjustment parameter are pre-determined and provided to the memory prior to the use of the sensor control device by the user.

4 . The glucose monitoring sensor control device of claim 1 , wherein the first adjustment parameter and second adjustment parameter are pre-determined in manufacture of the glucose sensor.

5 . The glucose monitoring sensor control device of claim 1 , wherein the instructions to determine the wear duration further cause the processing circuitry to calculate a difference between a supplied present time and a wear start time corresponding to a beginning of the duration of time after use of the sensor control device by the user.

6 . The glucose monitoring sensor control device of claim 1 , wherein the instructions to determine the wear duration further cause the processing circuitry to incorporate a wait period to the wear duration such that the wear duration corresponds to a duration of time less than the entire time after the use of the sensor control device by the user.

7 . The glucose monitoring sensor control device of claim 1 , wherein the memory further comprises instructions that, when executed by the processing circuitry cause the processing circuitry to:

detect that the glucose sensor has been positioned in the user, wherein the use of the sensor control device by the user corresponds to the detection that the glucose sensor has been positioned in the user.

8 . The glucose monitoring sensor control device of claim 1 , wherein the memory further comprises instructions that, when executed by the processing circuitry cause the processing circuitry to:

receive an electrical signal from the glucose sensor; and

detect the use of the sensor control device by the user based on receiving the electrical signal.

9 . The glucose monitoring sensor control device of claim 1 , wherein the use of the sensor control device by the user comprises activation of the sensor control device by an insertion device configured to position the second portion of the glucose sensor below the skin surface and in contact with the bodily fluid of the user.

10 . The glucose monitoring sensor control device of claim 1 , wherein the memory further comprises instructions that, when executed by the processing circuitry cause the processing circuitry to:

determine a shelf duration of the glucose sensor corresponding to the duration of time before use of the sensor control device by the user; and

algorithmically adjust the calibration parameter of the glucose sensor further with a third function including a third adjustment parameter and a value representative of the shelf duration.

11 . The glucose monitoring sensor control device of claim 10 , wherein the shelf duration corresponds to a duration of time after the glucose sensor has completed manufacturing.

12 . The glucose monitoring sensor control device of claim 10 , wherein the shelf duration corresponds to a duration of time after the glucose sensor has completed testing.

13 . The glucose monitoring sensor control device of claim 10 , wherein the shelf duration corresponds to a duration of time after the glucose sensor has completed assembly into the sensor control device.

14 . The glucose monitoring sensor control device of claim 10 , wherein the shelf duration corresponds to a duration of time after the glucose sensor has completed packaging.

15 . The glucose monitoring sensor control device of claim 1 , wherein the wear duration further corresponds to a duration of time after sensor data is first collected from the glucose sensor.

16 . The glucose monitoring sensor control device of claim 1 , wherein the wear duration further corresponds to a duration of time after the glucose level is first transmitted to the reader device.

17 . The glucose monitoring sensor control device of claim 1 , wherein:

the data indicative of the environmental exposure of the glucose sensor comprises temperature data representative of a plurality of temperatures to which the glucose sensor was subjected during the duration of time before use of the sensor control device by the user; and

the value representative of the environmental exposure of the glucose sensor comprises a value representative of the plurality of temperatures.

18 . The glucose monitoring sensor control device of claim 1 , wherein:

the data indicative of the environmental exposure of the glucose sensor comprises an aggregate temperature data value representative of aggregated thermal exposure of the glucose sensor during the duration of time before use of the sensor control device by the user; and

the value representative of the environmental exposure of the glucose sensor comprises a value representative of the aggregate temperature data.

19 . The glucose monitoring sensor control device of claim 1 , wherein the data indicative of the environmental exposure of the glucose sensor is indicative of exposure of the glucose sensor to humidity during the duration of time before use of the sensor control device by the user.

20 . The glucose monitoring sensor control device of claim 1 , wherein the data indicative of the environmental exposure of the glucose sensor is indicative of exposure of the glucose sensor to air pressure during the duration of time before use of the sensor control device by the user.

21 . The glucose monitoring sensor control device of claim 20 , wherein the sensitivity parameter is an offset of the linear sensitivity.

22 . The glucose monitoring sensor control device of claim 20 , wherein the sensitivity parameter is a slope of the linear sensitivity.

23 . The glucose monitoring sensor control device of claim 1 , wherein the calibration parameter comprises a sensitivity parameter for a linear sensitivity of the glucose sensor.

24 . A method of algorithmically processing glucose sensor data, comprising:

collecting data indicative of environmental exposure of a glucose sensor during a duration of time before use of the sensor control device by the user, wherein the glucose sensor is configured to detect glucose levels in a bodily fluid of a user such that a first portion of the glucose sensor is configured to reside above a skin surface of the user and a second portion of the glucose sensor is configured to reside below the skin surface and in contact with the bodily fluid of the user;

retrieving the data indicative of environmental exposure of the glucose sensor during the duration of time before use of the sensor control device by the user;

determining a wear duration of the glucose sensor, wherein the wear duration corresponds to a duration of time after use of the sensor control device by the user;

collecting, from the glucose sensor, sensor data including data indicative of a glucose level in the bodily fluid while the glucose sensor is in a position with the first portion of the glucose sensor above the skin surface of the user and the second portion of the glucose sensor below the skin surface and in contact with the bodily fluid of the user, the glucose sensor having been placed in the position with an insertion device, wherein the glucose sensor was electrically and communicatively coupled with processing circuitry of the sensor control device prior to placement of the glucose sensor in the position;

algorithmically adjusting a calibration parameter of the glucose sensor with: a first function including a first adjustment parameter and a value representative of the wear duration, and one or more additional functions including a second adjustment parameter and a value representative of the environmental exposure of the glucose sensor during the duration of time before use of the sensor control device by the user;

algorithmically processing the sensor data using the adjusted calibration parameter and to determine the glucose level in the bodily fluid; and

transmitting the determined glucose level to a reader device communicatively coupled with the sensor control device and configured to display the determined glucose level.

25 . The method of claim 24 , further comprising activating the sensor control device using the insertion device.

26 . An analyte monitoring system, comprising:

a glucose monitoring sensor control device comprising:

an adhesive patch configured to couple the glucose monitoring sensor control device to a skin surface of a user;

a glucose sensor configured to detect glucose levels in a bodily fluid of the user, wherein the glucose sensor is configured to be positioned in the user such that when operably positioned, a first portion of the glucose sensor is configured to reside above the skin surface of the user, and a second portion of the glucose sensor is configured to reside below the skin surface and in contact with the bodily fluid of the user;

an antenna;

sensor electronics and a power source coupled with the sensor electronics, wherein the sensor electronics comprise:

analog front end circuitry configured to interface with the glucose sensor and receive measurement data therefrom;

communication circuitry configured for wireless communication with a reader device by way of the antenna;

processing circuitry electrically and communicatively coupled with the analog front end circuitry and glucose sensor prior to the glucose sensor being positioned in the user; and

a memory electrically and communicatively coupled with the processing circuitry, the memory comprising instructions that, when executed by the processing circuitry, cause the processing circuitry to:

collect data indicative of environmental exposure of the glucose sensor during a duration of time before use of the sensor control device by the user;

determine a wear duration of the glucose sensor, wherein the wear duration corresponds to a duration of time after use of the sensor control device by the user;

collect, from the glucose sensor, sensor data including data indicative of a glucose level in the bodily fluid;

algorithmically adjust a calibration parameter of the glucose sensor with: a first function including a first adjustment parameter and a value representative of the wear duration, and one or more additional functions including a second adjustment parameter and a value representative of the environmental exposure of the glucose sensor during the duration of time before use of the sensor control device by the user;

algorithmically process the sensor data using the adjusted calibration parameter and to determine the glucose level in the bodily fluid; and

transmit the determined glucose level to a reader device communicatively coupled with the sensor control device and configured to display the determined glucose level, and

an insertion device configured to position the glucose monitoring sensor control device and the adhesive patch onto the skin surface of the user and to position the second portion of the glucose sensor below the skin surface and in contact with the bodily fluid of the user.

27 . The analyte monitoring system of claim 26 , wherein:

the data indicative of the environmental exposure of the glucose sensor comprises temperature data representative of a plurality of temperatures to which the glucose sensor was subjected during the duration of time before use of the sensor control device by the user; and

the value representative of the environmental exposure of the glucose sensor comprises a value representative of the plurality of temperatures.

28 . The analyte monitoring system of claim 26 , wherein the data indicative of the environmental exposure of the glucose sensor is indicative of exposure of the glucose sensor to humidity during the duration of time before use of the sensor control device by the user.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2023
From: BUDIMAN, ERWIN S.; BHOGAL, CLAIRE; SCOTT, STEVEN; TAUB, MARC B.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 062331/0551 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2023
From: BUDIMAN, ERWIN S.; BHOGAL, CLAIRE; TAUB, MARC B.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 062331/0689 →
Continuity (5)
Continuation 16204358 · Nov 29, 2018
Continuation PCTUS2018030619 · May 2, 2018
Provisional Application 62624665 · Jan 31, 2018
Provisional Application 62500955 · May 3, 2017
Related Publication 20220211307A1 · Jul 7, 2022
References Cited (400)
US 4592745A · Rex et al. · 1986 [cited by applicant]
US 4627445A · Garcia et al. · 1986 [cited by applicant]
US 4650547A · Gough · 1987 [cited by applicant]
US 4703756A · Gough et al. · 1987 [cited by applicant]
US 4750496A · Reinhart et al. · 1988 [cited by applicant]
US 4924879A · O'Brien · 1990 [cited by applicant]
US 5034112A · Murase et al. · 1991 [cited by applicant]
US 5089112A · Skotheim et al. · 1992 [cited by applicant]
US 5145381A · Volz · 1992 [cited by applicant]
US 5264103A · Yoshioka et al. · 1993 [cited by applicant]
US 5267963A · Bachynsky · 1993 [cited by applicant]
US 5318583A · Rabenau et al. · 1994 [cited by applicant]
US 5352351A · White et al. · 1994 [cited by applicant]
US 5390671A · Lord et al. · 1995 [cited by applicant]
US 5391250A · Cheney et al. · 1995 [cited by applicant]
US 5407431A · Botich et al. · 1995 [cited by applicant]
US 5411647A · Johnson et al. · 1995 [cited by applicant]
US 5497772A · Schulman et al. · 1996 [cited by applicant]
US 5584813A · Livingston et al. · 1996 [cited by applicant]
US 5626566A · Petersen et al. · 1997 [cited by applicant]
US 5695623A · Michel et al. · 1997 [cited by applicant]
US 5786439A · Van Antwerp et al. · 1998 [cited by applicant]
US 5791344A · Schulman et al. · 1998 [cited by applicant]
US 5863400A · Drummond et al. · 1999 [cited by applicant]
US 5865804A · Bachynsky · 1999 [cited by applicant]
US 5954643A · VanAntwerp et al. · 1999 [cited by applicant]
US 5971941A · Simons et al. · 1999 [cited by applicant]
US 6001067A · Shults et al. · 1999 [cited by applicant]
US 6093172A · Funderburk et al. · 2000 [cited by applicant]
US 6103033A · Say et al. · 2000 [cited by applicant]
US 6106484A · Terwilliger et al. · 2000 [cited by applicant]
US 6149626A · Bachynsky et al. · 2000 [cited by applicant]
US 6168957B1 · Matzinger et al. · 2001 [cited by applicant]
US 6175752B1 · Say et al. · 2001 [cited by applicant]
US 6212417B1 · Ikeda et al. · 2001 [cited by applicant]
US 6237394B1 · Harris et al. · 2001 [cited by applicant]
US 6259181B1 · Kawano et al. · 2001 [cited by applicant]
US 6275717B1 · Gross et al. · 2001 [cited by applicant]
US 6283982B1 · Levaughn et al. · 2001 [cited by applicant]
US 6293924B1 · Safabash et al. · 2001 [cited by applicant]
US 6293925B1 · Safabash et al. · 2001 [cited by applicant]
US 6360888B1 · McIvor et al. · 2002 [cited by applicant]
US 6366794B1 · Moussy et al. · 2002 [cited by applicant]
US 6368141B1 · VanAntwerp et al. · 2002 [cited by applicant]
US 6377829B1 · A1-Ali · 2002 [cited by applicant]
US 6400974B1 · Lesho · 2002 [cited by applicant]
US 6424847B1 · Mastrototaro et al. · 2002 [cited by applicant]
US 6475372B1 · Ohara et al. · 2002 [cited by applicant]
US 6475750B1 · Han et al. · 2002 [cited by applicant]
US 6522903B1 · Berman et al. · 2003 [cited by applicant]
US 6558321B1 · Burd et al. · 2003 [cited by applicant]
US 6560471B1 · Heller et al. · 2003 [cited by applicant]
US 6565509B1 · Say et al. · 2003 [cited by applicant]
US 6579690B1 · Bonnecaze et al. · 2003 [cited by applicant]
US 6587704B1 · Fine et al. · 2003 [cited by applicant]
US 6607543B2 · Purcell et al. · 2003 [cited by applicant]
US 6637611B2 · Luch · 2003 [cited by applicant]
US 6695860B1 · Ward et al. · 2004 [cited by applicant]
US 6809653B1 · Mann et al. · 2004 [cited by applicant]
US 6835553B2 · Han et al. · 2004 [cited by applicant]
US 6850859B1 · Schuh · 2005 [cited by applicant]
US 6931327B2 · Good, Jr. et al. · 2005 [cited by applicant]
US 6950028B2 · Zweig · 2005 [cited by applicant]
US 6960192B1 · Flaherty et al. · 2005 [cited by applicant]
US 6990366B2 · Say et al. · 2006 [cited by applicant]
US 7027859B1 · McNichols et al. · 2006 [cited by applicant]
US 7110803B2 · Shults et al. · 2006 [cited by applicant]
US 7144384B2 · Gorman et al. · 2006 [cited by applicant]
US 7207974B2 · Safabash et al. · 2007 [cited by applicant]
US 7220387B2 · Flaherty et al. · 2007 [cited by applicant]
US 7299082B2 · Feldman et al. · 2007 [cited by applicant]
US 7344500B2 · Talbot et al. · 2008 [cited by applicant]
US 7381184B2 · Funderburk et al. · 2008 [cited by applicant]
US 7481819B2 · Koeppel et al. · 2009 [cited by applicant]
US 7491303B2 · Sakata et al. · 2009 [cited by applicant]
US 7585287B2 · Bresina et al. · 2009 [cited by applicant]
US 7643798B2 · Ljung · 2010 [cited by applicant]
US 7699807B2 · Faust et al. · 2010 [cited by applicant]
US 7731691B2 · Cote et al. · 2010 [cited by applicant]
US 7837633B2 · Conway et al. · 2010 [cited by applicant]
US 7846132B2 · Gravesen et al. · 2010 [cited by applicant]
US 7867244B2 · Lathrop et al. · 2011 [cited by applicant]
US 7883473B2 · LeVaughn et al. · 2011 [cited by applicant]
US 7946984B2 · Brister et al. · 2011 [cited by applicant]
US 8016774B2 · Freeman et al. · 2011 [cited by applicant]
US 8028837B2 · Gerstle et al. · 2011 [cited by applicant]
US 8175673B2 · Say et al. · 2012 [cited by applicant]
US 8221332B2 · Robbins et al. · 2012 [cited by applicant]
US 8382681B2 · Escutia et al. · 2013 [cited by applicant]
US 8396670B2 · St-Pierre · 2013 [cited by applicant]
US 8398664B2 · Lamps et al. · 2013 [cited by applicant]
US 8469986B2 · Schraga · 2013 [cited by applicant]
US 8515519B2 · Brister et al. · 2013 [cited by applicant]
US 8747363B2 · Nielsen et al. · 2014 [cited by applicant]
US 8750955B2 · Brister et al. · 2014 [cited by applicant]
US 8945056B2 · Iio et al. · 2015 [cited by applicant]
US 9241631B2 · Valdes et al. · 2016 [cited by applicant]
US 9402544B2 · Yee et al. · 2016 [cited by applicant]
US 9474479B2 · Pusey et al. · 2016 [cited by applicant]
US 9504471B2 · Vaitekunas et al. · 2016 [cited by applicant]
US 9566384B2 · Gyrn et al. · 2017 [cited by applicant]
US 9668682B2 · Brister et al. · 2017 [cited by applicant]
US 9808574B2 · Yodfat et al. · 2017 [cited by applicant]
US 10292632B2 · Lee et al. · 2019 [cited by applicant]
US 10772547B1 · Lee et al. · 2020 [cited by applicant]
US 10820842B2 · Harper · 2020 [cited by applicant]
US 10827954B2 · Hoss et al. · 2020 [cited by applicant]
US 10874338B2 · Stafford · 2020 [cited by applicant]
US 10881341B1 · Curry et al. · 2021 [cited by applicant]
US 10945647B2 · Mazza et al. · 2021 [cited by applicant]
US 10945649B2 · Lee et al. · 2021 [cited by applicant]
US 10952653B2 · Harper · 2021 [cited by applicant]
US 10959654B2 · Curry et al. · 2021 [cited by applicant]
US 10966644B2 · Stafford · 2021 [cited by applicant]
US 10973443B2 · Funderburk et al. · 2021 [cited by applicant]
US 10980461B2 · Simpson et al. · 2021 [cited by applicant]
US 11000213B2 · Kamath et al. · 2021 [cited by applicant]
US 11000216B2 · Curry et al. · 2021 [cited by applicant]
US 11013440B2 · Lee et al. · 2021 [cited by applicant]
US 11020031B1 · Simpson et al. · 2021 [cited by applicant]
US 11064917B2 · Simpson et al. · 2021 [cited by applicant]
US 11141084B2 · Funderburk et al. · 2021 [cited by applicant]
US 11202591B2 · Yee et al. · 2021 [cited by applicant]
US 11298056B2 · Harper · 2022 [cited by applicant]
US 20020010390A1 · Guice et al. · 2002 [cited by applicant]
US 20020022855A1 · Bobroff et al. · 2002 [cited by applicant]
US 20020043651A1 · Darrow et al. · 2002 [cited by applicant]
US 20020161288A1 · Shin et al. · 2002 [cited by applicant]
US 20020169439A1 · Flaherty · 2002 [cited by applicant]
US 20020177764A1 · Sohrab · 2002 [cited by applicant]
US 20030003524A1 · Taniike et al. · 2003 [cited by applicant]
US 20030028184A1 · Lebel et al. · 2003 [cited by applicant]
US 20030076082A1 · Morgan et al. · 2003 [cited by applicant]
US 20030100821A1 · Heller et al. · 2003 [cited by applicant]
US 20030225373A1 · Bobroff et al. · 2003 [cited by applicant]
US 20040002682A1 · Kovelman et al. · 2004 [cited by applicant]
US 20040010207A1 · Flaherty et al. · 2004 [cited by applicant]
US 20040018486A1 · Dunn et al. · 2004 [cited by applicant]
US 20040022438A1 · Hibbard · 2004 [cited by applicant]
US 20040106858A1 · Say et al. · 2004 [cited by applicant]
US 20040127777A1 · Ruchti et al. · 2004 [cited by applicant]
US 20040133164A1 · Funderburk et al. · 2004 [cited by applicant]
US 20040186365A1 · Jin et al. · 2004 [cited by applicant]
US 20040204673A1 · Flaherty · 2004 [cited by applicant]
US 20040204687A1 · Mogensen et al. · 2004 [cited by applicant]
US 20040244151A1 · Sakata et al. · 2004 [cited by applicant]
US 20050004439A1 · Shin et al. · 2005 [cited by applicant]
US 20050027180A1 · Goode, Jr. et al. · 2005 [cited by applicant]
US 20050027463A1 · Goode, Jr. et al. · 2005 [cited by applicant]
US 20050038332A1 · Saidara et al. · 2005 [cited by applicant]
US 20050038465A1 · Shraga · 2005 [cited by applicant]
US 20050043598A1 · Goode, Jr. et al. · 2005 [cited by applicant]
US 20050059871A1 · Gough et al. · 2005 [cited by applicant]
US 20050069892A1 · Iyengar et al. · 2005 [cited by applicant]
US 20050101932A1 · Cote et al. · 2005 [cited by applicant]
US 20050143636A1 · Zhang et al. · 2005 [cited by applicant]
US 20050151976A1 · Toma · 2005 [cited by applicant]
US 20050215871A1 · Feldman et al. · 2005 [cited by applicant]
US 20050239154A1 · Feldman et al. · 2005 [cited by applicant]
US 20050245799A1 · Brauker et al. · 2005 [cited by applicant]
US 20050283114A1 · Bresina et al. · 2005 [cited by applicant]
US 20050283208A1 · Von Arx et al. · 2005 [cited by applicant]
US 20060019327A1 · Brister et al. · 2006 [cited by applicant]
US 20060020187A1 · Brister et al. · 2006 [cited by applicant]
US 20060020189A1 · Brister et al. · 2006 [cited by applicant]
US 20060020192A1 · Brister et al. · 2006 [cited by applicant]
US 20060036143A1 · Brister et al. · 2006 [cited by applicant]
US 20060081469A1 · Lee · 2006 [cited by applicant]
US 20060094944A1 · Chuang · 2006 [cited by applicant]
US 20060094945A1 · Barman et al. · 2006 [cited by applicant]
US 20060095014A1 · Ethelfeld · 2006 [cited by applicant]
US 20060142651A1 · Brister et al. · 2006 [cited by applicant]
US 20060155180A1 · Brister et al. · 2006 [cited by applicant]
US 20060222566A1 · Brauker et al. · 2006 [cited by applicant]
US 20060229512A1 · Petisce et al. · 2006 [cited by applicant]
US 20060258929A1 · Goode, Jr. et al. · 2006 [cited by applicant]
US 20060258959A1 · Sode · 2006 [cited by applicant]
US 20060281985A1 · Ward et al. · 2006 [cited by applicant]
US 20060293576A1 · Van Antwerp et al. · 2006 [cited by applicant]
US 20070016129A1 · Liniger et al. · 2007 [cited by applicant]
US 20070027381A1 · Stafford · 2007 [cited by applicant]
US 20070032706A1 · Kamath et al. · 2007 [cited by applicant]
US 20070038044A1 · Dobbles et al. · 2007 [cited by applicant]
US 20070060801A1 · Neinast · 2007 [cited by applicant]
US 20070073129A1 · Shah et al. · 2007 [cited by applicant]
US 20070093754A1 · Mogensen et al. · 2007 [cited by applicant]
US 20070135774A1 · Turner et al. · 2007 [cited by applicant]
US 20070142727A1 · Zhang et al. · 2007 [cited by applicant]
US 20070173710A1 · Petisce et al. · 2007 [cited by applicant]
US 20070208244A1 · Brauker et al. · 2007 [cited by applicant]
US 20070219480A1 · Kamen et al. · 2007 [cited by applicant]
US 20070249922A1 · Peyser et al. · 2007 [cited by applicant]
US 20070255116A1 · Mehta et al. · 2007 [cited by applicant]
US 20070299617A1 · Willis · 2007 [cited by applicant]
US 20080009692A1 · Stafford · 2008 [cited by applicant]
US 20080009805A1 · Ethefeld · 2008 [cited by applicant]
US 20080097246A1 · Stafford · 2008 [cited by applicant]
US 20080114280A1 · Stafford · 2008 [cited by applicant]
US 20080129486A1 · Jeckelmann et al. · 2008 [cited by applicant]
US 20080172205A1 · Breton et al. · 2008 [cited by applicant]
US 20080242962A1 · Roesicke et al. · 2008 [cited by applicant]
US 20080255440A1 · Eilersen et al. · 2008 [cited by applicant]
US 20080269687A1 · Chong et al. · 2008 [cited by applicant]
US 20080275313A1 · Brister et al. · 2008 [cited by applicant]
US 20080278333A1 · Fennell et al. · 2008 [cited by applicant]
US 20080281179A1 · Fennell et al. · 2008 [cited by applicant]
US 20080300476A1 · Stafford · 2008 [cited by applicant]
US 20080312842A1 · Hayter et al. · 2008 [cited by applicant]
US 20080319414A1 · Yodfat et al. · 2008 [cited by applicant]
US 20090054737A1 · Magar et al. · 2009 [cited by applicant]
US 20090076360A1 · Brister et al. · 2009 [cited by applicant]
US 20090099521A1 · Gravesen et al. · 2009 [cited by applicant]
US 20090102678A1 · Mazza et al. · 2009 [cited by applicant]
US 20090124979A1 · Raymond et al. · 2009 [cited by applicant]
US 20090143659A1 · Li et al. · 2009 [cited by applicant]
US 20090163789A1 · Say et al. · 2009 [cited by applicant]
US 20090178459A1 · Li et al. · 2009 [cited by applicant]
US 20090198186A1 · Mernoe et al. · 2009 [cited by applicant]
US 20090216215A1 · Thalmann et al. · 2009 [cited by applicant]
US 20090240121A1 · Bickoff · 2009 [cited by applicant]
US 20090247857A1 · Harper et al. · 2009 [cited by applicant]
US 20090291634A1 · Saarisalo · 2009 [cited by applicant]
US 20100045425A1 · Chivallier · 2010 [cited by applicant]
US 20100057042A1 · Hayter · 2010 [cited by applicant]
US 20100094111A1 · Heller et al. · 2010 [cited by applicant]
US 20100145377A1 · Lai et al. · 2010 [cited by applicant]
US 20100160759A1 · Celentano et al. · 2010 [cited by applicant]
US 20100198034A1 · Thomas et al. · 2010 [cited by applicant]
US 20100230285A1 · Hoss et al. · 2010 [cited by applicant]
US 20100274515A1 · Hoss et al. · 2010 [cited by applicant]
US 20110021889A1 · Hoss et al. · 2011 [cited by applicant]
US 20110058485A1 · Sloan · 2011 [cited by applicant]
US 20110178378A1 · Mernoe et al. · 2011 [cited by applicant]
US 20110193704A1 · Harper et al. · 2011 [cited by applicant]
US 20110210830A1 · Talty et al. · 2011 [cited by applicant]
US 20110213225A1 · Bernstein et al. · 2011 [cited by applicant]
US 20110319729A1 · Donnay et al. · 2011 [cited by applicant]
US 20110320130A1 · Valdes et al. · 2011 [cited by applicant]
US 20120003933A1 · Baker et al. · 2012 [cited by applicant]
US 20120078071A1 · Bohm et al. · 2012 [cited by applicant]
US 20120084053A1 · Yuen et al. · 2012 [cited by applicant]
US 20120233679A1 · Shedrinsky · 2012 [cited by applicant]
US 20120238851A1 · Kamen et al. · 2012 [cited by applicant]
US 20120255875A1 · Vicente et al. · 2012 [cited by applicant]
US 20120265037A1 · Bohm · 2012 [cited by examiner]
US 20120309302A1 · Buhot · 2012 [cited by applicant]
US 20140188402A1 · Garcia et al. · 2014 [cited by applicant]
US 20150005601A1 · Hoss et al. · 2015 [cited by applicant]
US 20150018639A1 · Stafford · 2015 [cited by applicant]
US 20150025345A1 · Funderburk et al. · 2015 [cited by applicant]
US 20150173661A1 · Myles · 2015 [cited by applicant]
US 20170074757A1 · Garcia et al. · 2017 [cited by applicant]
US 20170112531A1 · Schoonmaker et al. · 2017 [cited by applicant]
US 20190274598A1 · Scott et al. · 2019 [cited by applicant]
CA 2766693 · 2011 [cited by applicant]
CA 2766685 · 2011 [cited by applicant]
DE 202015010002U1 · 2022 [cited by applicant]
EP 1391728 · 2004 [cited by applicant]
EP 1413879 · 2012 [cited by applicant]
EP 2498196 · 2012 [cited by applicant]
EP 3575796 · 2019 [cited by applicant]
EP 3730045 · 2022 [cited by applicant]
EP 1789116 · 2023 [cited by applicant]
WO WO9718639 · 1997 [cited by applicant]
WO WO0049941 · 2000 [cited by applicant]
WO WO200117875 · 2001 [cited by applicant]
WO WO02058537 · 2002 [cited by applicant]
WO WO2002058537 · 2002 [cited by applicant]
WO WO03012422 · 2003 [cited by applicant]
WO WO03026728 · 2003 [cited by applicant]
WO WO03032411 · 2003 [cited by applicant]
WO WO03094714 · 2003 [cited by applicant]
WO WO2004006982 · 2004 [cited by applicant]
WO WO2004098682 · 2004 [cited by applicant]
WO WO2005011489 · 2005 [cited by applicant]
WO WO2005011779 · 2005 [cited by applicant]
WO WO2005046780 · 2005 [cited by applicant]
WO WO2005070287 · 2005 [cited by applicant]
WO WO2006026741 · 2006 [cited by applicant]
WO WO2006121921 · 2006 [cited by applicant]
WO WO2008021913 · 2008 [cited by applicant]
WO WO2008073813 · 2008 [cited by applicant]
WO WO2008114223 · 2008 [cited by applicant]
WO WO2008115409 · 2008 [cited by applicant]
WO WO2008155377 · 2008 [cited by applicant]
WO WO2008157821 · 2008 [cited by applicant]
WO WO2009001347 · 2008 [cited by applicant]
WO WO2009007287 · 2009 [cited by applicant]
WO WO2009035773 · 2009 [cited by applicant]
WO WO2009039013 · 2009 [cited by applicant]
WO WO2009066288 · 2009 [cited by applicant]
WO WO2010099507 · 2010 [cited by applicant]
WO WO2011011643 · 2011 [cited by applicant]
WO WO2012142502 · 2012 [cited by applicant]
WO WO2013019225 · 2013 [cited by applicant]
WO WO2013090791 · 2013 [cited by applicant]
U.S. Appl. No. 16/204,358 (2019/0117138), filed Nov. 29, 2018 (Apr. 25, 2019). [cited by applicant]
U.S. Appl. No. 16/204,358, filed May 20, 2022 Advisory Action. [cited by applicant]
U.S. Appl. No. 16/204,358, filed May 17, 2022 Response after Final Office Action. [cited by applicant]
U.S. Appl. No. 16/204,358, filed Mar. 22, 2022 Final Office Action. [cited by applicant]
U.S. Appl. No. 16/204,358, filed Dec. 27, 2021 Response after Non-Final Office Action. [cited by applicant]
U.S. Appl. No. 16/204,358, filed Sep. 24, 2021 Non-Final Office Action. [cited by applicant]
U.S. Appl. No. 16/204,358, filed Aug. 25, 2021 Response to Restriction Requirement. [cited by applicant]
U.S. Appl. No. 16/204,358, filed Jun. 25, 2021 Restriction Requirement. [cited by applicant]
WO PCT/US2018/030619 ISR and Written Opinion Jun. 26, 2018. [cited by applicant]
Hoss, U., et al., “Factory-Calibrated Continuous Glucose Sensors: The Science Behind the Technology”, Diabetes Technology & Therapeutics, 2017, vol. 19, No. S2, pp. 5-44-5-50. [cited by applicant]
Pavelkova, A., “Time Temperature Indicators as Devices Intelligent Packaging,” Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, 2013, vol. LXI, No. 1, pp. 245-251. [cited by applicant]
U.S. Appl. No. 61/227,967, filed Jul. 23, 2009, Hoss, et al. [cited by applicant]
“Blood glucose monitoring” retrieved from “https://web.archive.org/web/20111215063153/http://en.wikipedia.org/wiki/Blood_glucose_monitoring” on Aug. 1, 2021, 6 pages. [cited by applicant]
“In Vivo Glucose Sensing”, Chemical Analysis, A Series of Monographs on Analytical Chemistry and its Applications, vol. 174, 466 pages (2010). [cited by applicant]
“In Vivo Glucose Sensing”, Chemical Analysis, A Series of Monographs on Analytical Chemistry and its Applications, vol. 174, 62 pages (2010). [cited by applicant]
“Near field communication” retrieved from “http://en.wikipedia.org/w/index.php?title=Near_field_communication&oldid=543740757” on Jun. 27, 2014, 14 pages. [cited by applicant]
Alcock, et al., “Continuous Analyte Monitoring to Aid Clinical Practice”, IEEE Engineering in Medicine and Biology, pp. 319-325 (1994). [cited by applicant]
Bard, et al., Electrochemical Methods, Fundamentals and Applications, pp. 174-175 (1980). [cited by applicant]
Bequette, “Continuous Glucose Monitoring: Real Time Algorithms for Calibration, Filtering, and Alarms”, Journal of Diabetes Science and Technology, 4(2):404-418 (2010). [cited by applicant]
Cengiz, et al., “A Tale of Two Compartments: Interstitial Versus Blood Glucose Monitoring”, Diabetes Technology & Therapeutics, 11(1):S-11-S16 (2009). [cited by applicant]
Chen, et al., “Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor”, Clin Chem Lab Med, 40(8):786-789 (2002). [cited by applicant]
Chen, et al., “Glucose microbiosensor based on alumina sol gel matrix/eletropolymerized composite membrane”, Biosensors and Bioelectronics, 17:1005-1013 (2002). [cited by applicant]
Chen, et al., “In Situ Assembled Mass-Transport Controlling Micromembranes and Their Application in Implanted Amperometric Glucose Sensors”, Analytical Chemistry, 72(16):3757-3763 (2000). [cited by applicant]
Chen, et al., “In vivo Glucose Monitoring with Miniature “Wired” Glucose Oxidase Electrodes”, Analytical Sciences, 17:i297-i300 (2001). [cited by applicant]
Choleau, et al., “Calibration of a subcutaneous amperometric glucose sensor Part 1. Effect of measurement uncertainties on the determination of sensor sensitivity and background current”, Biosensors and Bioelectronics, … [cited by applicant]
Chung, “In vitro Evaluation of the Continuous Monitoring Glucose Sensors with Perfluorinated Tetrafluoroethylene Coatings”, Bull. Korean Chem. Soc., 24(4):514-516 (2003). [cited by applicant]
Csöregi, et al., “Design, Characterization, and One-Point in Vivo Calibration of a Subcutaneously Implanted Glucose Electrode”, Anal. Chem., 66(19):3131-3138 (1994). [cited by applicant]
De Block, et al., “Minimally-Invasive and Non-Invasive Continuous Glucose Monitoring Systems: Indications, Advantages, Limitations and Clinical Aspects”, Current Diabetes Reviews, 4:159-168 (2008). [cited by applicant]
Decuir, “Bluetooth 4.0:Low Energy”, Standards Architect, CSR Technology, Councilor, Bluetooth Architecture Review Board, IEEE Region 6 Northwest Area Chair, 104 pages (2012). [cited by applicant]
Dementyev, et al., “Power Consumption Analysis of Bluetooth Low Energy, ZigBee and ANT Sensor Nodes in a Cyclic Sleep Scenario”, IEEE International Wireless Symposium (IWS), 5 pages (2013). [cited by applicant]
DexCom™ STS™ Continuous Glucose Monitoring System, User's Guide, DexCom, Inc., 57 pages (2006). [cited by applicant]
Facchinetti, et al., “Enhanced Accuracy of Continuous Glucose Monitoring by Online Extended Kalman Filtering”, Diabetes Technology & Therapeutics, 12(5):353-363 (2010). [cited by applicant]
Feldman, et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, 5(5):769-779 (2003). [cited by applicant]
Fischer, “Fundamentals of Glucose Sensors”, Diabetic Medicine, 8:309-321 (1991). [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, Summary of Safety and Effectiveness Data in support of Pre-Market Approval (PMA) No. P050020, Abbott Diabetes Care, 27 pages (2008). [cited by applicant]
FreeStyle Navigator Continuous Glucose Monitoring System, User Guide, Abbott Diabetes Care Inc., 195 pages (2008). [cited by applicant]
Gerritsen, et al., “Subcutaneously implantable glucose sensors in patients with diabetes mellitus; still many problems”, Dutch Journal of Medicine, 146(28):1313-1316 (2002) (with English Machine Translation). [cited by applicant]
Guardian® Real-Time, Continuous Glucose Monitoring System, User Guide, Medtronic MiniMed, Inc., 181 pages (2006). [cited by applicant]
Guardian® RT, Continuous Glucose Monitoring System, REF MMT-7900, User Guide, Medtronic MiniMed, 128 pages (2005). [cited by applicant]
Heinemann, “Continuous Glucose Monitoring by Means of the Microdialysis Technique: Underlying Fundamental Aspects”, Diabetes Technology & Therapeutics, 5(4):545-561 (2003). [cited by applicant]
Heise, et al., “Hypoglycemia Warning Signal and Glucose Sensors: Requirements and Concepts”, Diabetes Technology & Therapeutics, 5(4):563-571 (2003). [cited by applicant]
Heller, “Implanted Electrochemical Glucose Sensors for the Management of Diabetes”, Annu. Rev. Biomed. Eng., 01:153-175 (1999). [cited by applicant]
Heller, et al., “Electrochemical Glucose Sensors and Their Applications in Diabetes Management”, Chemical Reviews, 108(7):2482-2505 (2008). [cited by applicant]
Jiménez, et al., “Glucose sensor based on an amperometric microelectrode with a photopolymerizable enzyme membrane”, Sensors and Actuators B, 26-27:421-424 (1995). [cited by applicant]
Johnson, et al., “Reduction of Electrooxidizable Interferent Effects: Optimization of the Applied Potential for Amperometric Glucose Sensors”, Electroanalysis, 6:321-326 (1994). [cited by applicant]
Klonoff, “A Review of Continuous Glucose Monitoring Technology”, Diabetes Technology & Therapeutics, 7(5):770-775 (2005). [cited by applicant]
Klonoff, “Continuous Glucose Monitoring: Roadmap for 21st century diabetes therapy”, Diabetes Care, 28(5):1231-1239 (2005). [cited by applicant]
Knobbe, et al., “The Extended Kalman Filter for Continuous Glucose Monitoring”, Diabetes Technology & Therapeutics, 7(1):15-27 (2005). [cited by applicant]
Koudelka, et al., “In-vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors”, Biosensors & Bioelectronics, 6:31-36 (1991). [cited by applicant]
Koudelka-Hep, “Electrochemical Sensors for in vivo Glucose Sensing”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 57-77 (1997). [cited by applicant]
Kuure-Kinsey, et al., “A Dual-Rate Kalman Filter for Continuous Glucose Monitoring”, Proceedings of the 28th IEEE, EMBS Annual International Conference, pp. 63-66 (2006). [cited by applicant]
Kvist, et al., “Recent Advances in Continuous Glucose Monitoring: Biocompatibility of Glucose Sensors for Implantation in Subcutis”, Journal of Diabetes Science and Technology, 1(5):746-752 (2007). [cited by applicant]
Lodwig, et al., “Continuous Glucose Monitoring with Glucose Sensors: Calibration and Assessment Criteria”, Diabetes Technology & Therapeutics, 5(4):573-587 (2003). [cited by applicant]
Ming Li, et al., “Implantable Electrochemical Sensors for Biomedical and Clinical Applications: Progress, Problems, and Future Possibilities”, Current Medicinal Chemistry, 14:937-951 (2007). [cited by applicant]
Moatti-Sirat, et al., “Evaluating in vitro and in vivo the interference of ascorbate and acetaminophen on glucose detection by a needle-type glucose sensor”, Biosensors and Bioelectronics, 7(5):345-352 (1992). [cited by applicant]
Morak, et al., “Design and Evaluation of a Telemonitoring Concept Based on NFC-Enabled Mobile Phones and Sensor Devices”, IEEE Transactions on Information Technology in Biomedicine, 16(1):17-23 (2012). [cited by applicant]
Movassaghi, et al., “Wireless Technologies for Body Area Networks: Characteristics and Challenges”, IEEE, International Symposium on Communications and Information Technologies (ISCIT), pp. 42-47 (2012). [cited by applicant]
Nishida, et al., “Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate”, Medical Progress th… [cited by applicant]
Onuki, et al., “A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response”, Journal of Diabetes Science and Technology, 2(6):1003-1015 (2008). [cited by applicant]
Palerm, et al., “Hypoglycemia Prediction and Detection Using Optimal Estimation”, Diabetes Technology & Therapeutics, 7(1):3-14 (2005). [cited by applicant]
Poitout, et al., “Calibration in dogs of a subcutaneous miniaturized glucose sensor using a glucose meter for blood glucose determination”, Biosensors & Bioelectronics, 7:587-592 (1992). [cited by applicant]
Rebrin, et al., “Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring”, American Journal of Physiology-Endocrinology and Metabolism, 277(3):E561-E571 (1999). [cited by applicant]
Renard, “Implantable glucose sensors for diabetes monitoring”, Min Invas Ther & Allied Technol, 13(2):78-86 (2004). [cited by applicant]
Rhodes, et al., “Prediction of Pocket-Portable and Implantable Glucose Enzyme Electrode Performance from Combined Species Permeability and Digital Simulation Analysis”, Analytical Chemistry, 66(9):1520-1529 (1994). [cited by applicant]
Robert, “Continuous Monitoring of Blood Glucose”, Horm Res 57(suppl 1):81-84 (2002). [cited by applicant]
Schlosser, et al., “Biocompatibility of Active Implantable Devices”, Biosensors in the Body: Continuous in vivo Monitoring, pp. 139-170 (1997). [cited by applicant]
Schmidt, et al., “Calibration of a wearable glucose sensor”, The International Journal of Artificial Organs, 15(1):55-61 (1992). [cited by applicant]
Schmidtke, et al., “Accuracy of the One-Point in Vivo Calibration of “Wired” Glucose Oxidase Electrodes Implanted in Jugular Veins of Rats in Periods of Rapid Rise and Decline of the Glucose Concentration”, Anal. Chem.,… [cited by applicant]
Specification of the Bluetooth System, Experience More, Specification vol. 0, Covered Core Package Version: 4.0, 2 302 pages (2010). [cited by applicant]
Tierney, et al., “Effect of Acetaminophen on the Accuracy of Glucose Measurements Obtained with the GlucoWatch Biographer”, Diabetes Technology & Therapeutics, 2(2):199-207 (2000). [cited by applicant]
Townsend, et al., “Getting Started with Bluetooth Low Energy [Book]”, O'Reilly, retrieved from https://www.oreilly.com/library/view/getting-started-with/9781491900550/ch01.html on May 5, 2020, 26 pages. [cited by applicant]
Velho, et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomed. Biochim. Acta, vol. 48, pp. 957-964 (1989). [cited by applicant]
Voskerician, et al., “Sensor Biocompatibility and Biofouling in Real-Time Monitoring”, Wiley Encyclopedia of Biomedical Engineering, (John Wiley & Sons, Inc.), pp. 1-19 (2006). [cited by applicant]
Ward, “A Review of the Foreign-body Response to Subcutaneously-implanted Devices: The Role of Macrophages and Cytokines in Biofouling and Fibrosis”, Journal of Diabetes Science and Technology, 2(5):768-777 (2008). [cited by applicant]
Ward, et al., “A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation”, Biosensors & Bioelectronics, 17:181-189 (2002). [cited by applicant]
Yang, et al., “Glucose Biosensors Based on Oxygen Electrode with Sandwich-Type Membranes”, Annals of Biomedical Engineering, 23:833-839 (1995). [cited by applicant]
Yang, et al., “Glucose Biosensors with Enzyme Entrapped in Polymer Coating”, Biomedical Instrumentation & Technology, 29(2):125-133 (1995). [cited by applicant]
Abbott Press Release—“Abbott Receives CE Mark for FreeStyle® Libre, A Revolutionary Glucose Monitoring System for People with Diabetes” retrieved from https://abbott.mediaroom.com/2014-09-03-Abbott-Receives-CE-Mark-for-… [cited by applicant]
Abbott Press Release—“Abbott Receives FDA Approval for the FreeStyle LibrePro™ System, A Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with their Patients” retrieved from https://abbott.m… [cited by applicant]
Abbott Press Release—“Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S.” retrieved from https://abbott.mediaroom.com/2018-07-27-Abbotts-FreeStyle-R-Libre-14-Day-Flash-Glucose-Monitori… [cited by applicant]
[cited by applicant]
Anzhsn, National Horizon Scanning Unit Horizon Scanning Report, “GlucoWatch® G2 Biographer for the non-invasive monitoring of glucose levels”, 46 pages, May 2004. [cited by applicant]
Cather, CGM Frustrations Survey dated Jun. 2020, 37 pages in [cited by applicant]
Certified Copy U.S. Pat. No. 11,000,216, issued on May 11, 2021, 86 pages. [cited by applicant]
Clinical Trials, Competitor and Ecosystem Players dated Jun. 25, 2020, 29 pages in [cited by applicant]
Declaration of Dr. Anthony Edward Cass in Support of Petition for Inter Partes Review of U.S. Pat. No. 11,020,031 in [cited by applicant]
Declaration of Karl R. Leinsing, MSME, PE, in Support of Abbott's Motion for Summary Judgment dated May 19, 2023, 81 pages in [cited by applicant]
Design Concepts, Project Status Update for Glucose Sensor Applicator, Dexcom, dated Apr. 21, 2014, 6 pages. [cited by applicant]
Direct Examination of Neil Sheehan, filed May 31, 2024, ADC-1 (30 pages) & ADC-2 (30 pages). [cited by applicant]
Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System, DexCom, Inc., U.S. National Library of Medicine, ClinicalTrials.gov Identifier: NCT01111370, 4 pages (2017). [cited by applicant]
Design U.S. Appl. No. 29/101,218, filed Feb. 25, 1999, 11 pages. [cited by applicant]
Fraser, “An Introduction to in vivo Biosensing: Progress and Problems”, Biosensors in the Body: Continuous In Vivo Monitoring, pp. 1-56 (1997). [cited by applicant]
FreeStyle Libre 2 HCP Pulse, Mar. 2021 Report, dated Apr. 13, 2021, 14 pages in [cited by applicant]
Godek, et al., Chapter 2, “The Macrophage in Wound Healing Surrounding Implanted Devices”, In Vivo Glucose Sensing, 36 pages (2010). [cited by applicant]
Gross, et al., “Performance Evaluation of the MiniMed® Continuous Glucose Monitoring System During Patient Home Use”, Diabetes Technology & Therapeutics, vol. 2, No. 1, pp. 49-56 (2000). [cited by applicant]
Heller, “Integrated Medical Feedback Systems for Drug Delivery”, American Institute of Chemical Engineers Journal, vol. 51, No. 4, pp. 1054-1066 (2005). [cited by applicant]
Henning, Chapter 5, “Commercially Available Continuous Glucose Monitoring Systems”, In Vivo Glucose Sensing, 50 pages (2010). [cited by applicant]
Kovatchev, et al., “Evaluating the Accuracy of Continuous Glucose-Monitoring Sensors”, Diabetes Care, vol. 27, No. 8, pp. 1922-1928 (2004). [cited by applicant]
Lesperance, et al., “Calibration of the Continuous Glucose Monitoring System for Transient Glucose Monitoring”, Diabetes Technology & Therapeutics, vol. 9, No. 2, pp. 183-190 (2007). [cited by applicant]
Schlosser, et al., “Biocompatibility of Active Implantable Devices”, Biosensors in the Body: Continuous in vivo Monitoring, 34 pages (1997). [cited by applicant]
Seagrove Partners, International Diabetes Device, 2022 Blue Book dated 2022, 143 pages in [cited by applicant]
Wilson et al., Chapter 1, “Introduction to the Glucose Sensing Problem,” In Vivo Glucose Sensing, 32 pages (2010). [cited by applicant]
Wisniewski, et al., “Characterization of implantable biosensor membrane biofouling”, Fresenius J Anal Chem, 366:611-621 (2000). [cited by applicant]
Declaration of Gary D. Fletcher, Ph.D., dated Oct. 10, 2023 for IPR2023-01409, U.S. Pat. No. 11,202,591 (U.S. Appl. No. 17/221,154). [cited by applicant]